In the last three months, 11 analysts have published ratings on Unum Gr UNM, offering a diverse range of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 2 | 6 | 3 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 2 | 1 | 0 | 0 |
2M Ago | 1 | 1 | 0 | 0 | 0 |
3M Ago | 1 | 2 | 2 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $79.0, a high estimate of $96.00, and a low estimate of $64.00. Observing a 8.82% increase, the current average has risen from the previous average price target of $72.60.
Decoding Analyst Ratings: A Detailed Look
An in-depth analysis of recent analyst actions unveils how financial experts perceive Unum Gr. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Jack Matten | BMO Capital | Announces | Outperform | $91.00 | - |
Elyse Greenspan | Wells Fargo | Raises | Overweight | $81.00 | $74.00 |
Jimmy Bhullar | JP Morgan | Raises | Neutral | $79.00 | $74.00 |
Alex Scott | Barclays | Raises | Overweight | $85.00 | $76.00 |
John Barnidge | Piper Sandler | Raises | Overweight | $82.00 | $74.00 |
Suneet Kamath | Jefferies | Raises | Buy | $96.00 | $91.00 |
Mark Hughes | Truist Securities | Raises | Buy | $75.00 | $70.00 |
Alex Scott | Barclays | Raises | Overweight | $76.00 | $74.00 |
Alex Scott | Barclays | Raises | Overweight | $74.00 | $72.00 |
Nigel Dally | Morgan Stanley | Raises | Equal-Weight | $64.00 | $62.00 |
Thomas Gallagher | Evercore ISI Group | Raises | In-Line | $66.00 | $59.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Unum Gr. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Unum Gr compared to the broader market.
- Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Unum Gr's stock. This comparison reveals trends in analysts' expectations over time.
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Unum Gr's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on Unum Gr analyst ratings.
All You Need to Know About Unum Gr
Unum Group is a provider of group and individual income protection insurance products in the United States, the United Kingdom, Poland, and other countries. It is the largest domestic disability insurer, with the majority of premiums generated from employer plans. The company also offers a complementary portfolio of other insurance products, including long-term care insurance, life insurance, and employer- and employee-paid group benefits. It has the following operating business segments: Unum US, Unum International, and Colonial Life. The majority of the revenue is earned from the Unum US segment. The firm markets its products primarily through brokers.
Understanding the Numbers: Unum Gr's Finances
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Unum Gr's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 4.34%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Unum Gr's net margin is impressive, surpassing industry averages. With a net margin of 20.16%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Unum Gr's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 6.03%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Unum Gr's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.02%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.32.
The Core of Analyst Ratings: What Every Investor Should Know
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.